10x Genomics is trading at $79.90, up +4.31%, alongside a stronger risk-on session led by technology and AI-linked stocks.
- The S&P 500 is up 0.80% and the Nasdaq Composite is up 1.32%.
- Falling oil prices and Treasury yields are improving sentiment.
- Bitcoinβs surge and optimism around U.S.-China talks are supporting risk appetite. No new company-specific announcement was identified on September 21, 2026; the Lunit oncology-AI collaboration was announced September 10.